Meet our team

Martin is a Research Scientist and joins the team in Spain to progress Stablepharma's RNA-LNP vaccine thermostabilisation programme.

Professor Jonathan Van-Tam is a physician, public health specialist and an expert on respiratory viruses and pandemics.

With a BSc in Biology and an MSc in Bioinformatics from the University of Edinburgh, Tom has joined the Stablepharma team, based in the London office.

Dr Kenny Simmen, a Stablepharma Advisory Board Member was, up to recently, part of the Johnson & Johson Infectious Diseases & Vaccines leadership team.

Two decades in the biopharmaceutical industry, working for blue chip companies such as Pfizer, IQVIA and Pharmacia. Click for more.

Dr Chatfield works as a consultant to the Biopharma industry and has a proven track record of success through all stages of product discovery and development leading to registration.

Dr O’Halon joined Stablepharma as head of Clinical Development from Boyds Consulting, where she was VP of Clinical Operations. She is leading the clinical development of SPVX02 in collaboration with the University Hospital Southampton NHS Foundation Trust.

Experienced company leader, business developer, multi-disciplined & experienced in UK & International markets. Click for bio.

Neil has over 32 years of experience as a consultant and consulting practice leader within the Financial Services industry. Click for bio.

PhD in Biotechnology and BSc Honours in Microbiology, Genetics and Immunology. Click for bio.

Stephanie Maley, Chief People Officer, is a ‘people professional’ with over 25 years’ experience working with a wide cross-section of businesses.

Juana, with degrees in Molecular Biology and Biochemistry, manages our R&D projects including testing and validation. Click for bio.

Professor of Paediatric Immunology and Infectious Diseases at the University of Southampton and Director of the NIHR Southampton Clinical Research Facility.

Dr Ceri Elizabeth Morgan MB ChB, has worked extensively across the healthcare industry advising on IPO strategy and primary capital raises.

A distinguished international career in biomedical research with 108 refereed papers and 49 patents. Click for Bio.

CEO Boyd Consultants, Past President of Faculty of Pharmaceutical Medicine, Former Head of Medical Research for Zeneca. Click for bio.

Michelle has over 15 years of experience as an accountant in a variety of business sectors such as healthcare, shipping and is a fellow of Chartered Accountants Ireland.

Senior marketing and Communications executive with experience in big pharma product launch communications. Click for bio.

Shankar has a wealth of experience working with biologics and vaccines, lyophilisation techniques, in addition to being an experienced auditor to support the vendor qualification program.

A results focused senior advisor and consultant with 25+ years’ experience. Click for bio.

Ex. VP Sub-Saharan Africa, for GSK & Founder and Chairman One Family Health. Click for bio.

Richard Lane is a corporate lawyer and his expertise spans fundraising, mergers and acquisitions for private and corporate businesses.

Lorena has a Master’s Degree and PhD in Molecular Biosciences from the Universidad Autónoma de Madrid and was until recently a Postdoctoral researcher at the National Biotechnology Centre (CNB-CSIC) at the department of macromolecular structure.

Johnny Sutton joins the Board of Stablepharma, with extensive experience within the Investment Banking Industry, including Wood Mackenzie & Co, UBS and Dresdner Kleinwort Wasserstein. Click here for Bio.